170 related articles for article (PubMed ID: 15265190)
61. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
Lucidarme N; Ruiz JC; Czernichow P; Léger J
J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
[TBL] [Abstract][Full Text] [Related]
62. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
63. Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities.
Benbassat CA; Eshed V; Kamjin M; Laron Z
J Clin Endocrinol Metab; 2003 Oct; 88(10):4586-9. PubMed ID: 14557426
[TBL] [Abstract][Full Text] [Related]
64. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
Yamazaki S; Ichimura S; Iwamoto J; Takeda T; Toyama Y
J Bone Miner Metab; 2004; 22(5):500-8. PubMed ID: 15316873
[TBL] [Abstract][Full Text] [Related]
65. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.
Phabphal K; Geater A; Limapichart K; Sathirapanya P; Setthawatcharawanich S; Witeerungrot N; Thammakumpee N; Leelawattana R
Epilepsia; 2013 Feb; 54(2):249-55. PubMed ID: 23281616
[TBL] [Abstract][Full Text] [Related]
66. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women.
Liu SZ; Tian LF; Xu P; Zhuang GH; Zheng F; Tian J; Ning QL; Zhu BF; Lu SM; Yan H
Mol Biol Rep; 2011 Feb; 38(2):939-48. PubMed ID: 20490690
[TBL] [Abstract][Full Text] [Related]
67. Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients.
Koo DL; Nam H
Epilepsia; 2020 Oct; 61(10):2142-2149. PubMed ID: 32944954
[TBL] [Abstract][Full Text] [Related]
68. Fractures in epilepsy children.
Gniatkowska-Nowakowska A
Seizure; 2010 Jul; 19(6):324-5. PubMed ID: 20493726
[TBL] [Abstract][Full Text] [Related]
69. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
70. Antiepileptic Drugs and Bone Health in Thai Children with Epilepsy.
Paticheep S; Chotipanich C; Khusiwilai K; Wichaporn A; Khongsaengdao S
J Med Assoc Thai; 2015 Jun; 98(6):535-41. PubMed ID: 26219156
[TBL] [Abstract][Full Text] [Related]
71. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
[TBL] [Abstract][Full Text] [Related]
72. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
73. Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice.
Anwar MJ; Radhakrishna KV; Vohora D
Can J Physiol Pharmacol; 2014 Jun; 92(6):507-11. PubMed ID: 24761981
[TBL] [Abstract][Full Text] [Related]
74. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3.
Kumandas S; Koklu E; Gümüs H; Koklu S; Kurtoglu S; Karakukcu M; Keskin M
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):529-34. PubMed ID: 16759039
[TBL] [Abstract][Full Text] [Related]
75. Bone mineral density in long-term survivors of highly malignant osteosarcoma.
Holzer G; Krepler P; Koschat MA; Grampp S; Dominkus M; Kotz R
J Bone Joint Surg Br; 2003 Mar; 85(2):231-7. PubMed ID: 12678358
[TBL] [Abstract][Full Text] [Related]
76. Effect of carbamazepine and valproate on bone mineral density.
Sheth RD; Wesolowski CA; Jacob JC; Penney S; Hobbs GR; Riggs JE; Bodensteiner JB
J Pediatr; 1995 Aug; 127(2):256-62. PubMed ID: 7636651
[TBL] [Abstract][Full Text] [Related]
77. The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.
Pitetzis DA; Spilioti MG; Yovos JG; Yavropoulou MP
Seizure; 2017 May; 48():36-43. PubMed ID: 28391043
[TBL] [Abstract][Full Text] [Related]
78. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia.
Leonard MB; Propert KJ; Zemel BS; Stallings VA; Feldman HI
J Pediatr; 1999 Aug; 135(2 Pt 1):182-8. PubMed ID: 10431112
[TBL] [Abstract][Full Text] [Related]
79. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis.
Zhang Y; Zheng YX; Zhu JM; Zhang JM; Zheng Z
J Zhejiang Univ Sci B; 2015 Jul; 16(7):611-21. PubMed ID: 26160719
[TBL] [Abstract][Full Text] [Related]
80. Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state.
Yoshikawa H; Yamazaki S; Watanabe T; Abe T
Brain Dev; 2003 Apr; 25(3):186-90. PubMed ID: 12689697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
